欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/0743/002
药品名称
Olmesartan + Hidroclorotiazida Teva
活性成分
hydrochlorothiazide 25.0 mg
olmesartan medoxomil 20.0 mg
剂型
Film-coated tablet
上市许可持有人
Teva Pharma - Produtos Farmacêuticos, Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Austria (AT)
Olmesartan/HCT ratiopharm 20 mg/25 mg Filmtabletten
许可日期
2012/06/21
最近更新日期
2022/07/09
药物ATC编码
C09DA08 olmesartan medoxomil and diuretics
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
Olmesartan_HCT 20 mg_12,5_25 mg-PIL-clean-20.06.12
Date of last change:2012/10/04
Final SPC
|
Olmesartan_HCT 20 mg_12,5_25 mg-SmPC-clean-20.06.12
Date of last change:2012/10/04
Final PL
|
Olmesartan_HCT 40 mg_12,5_25 mg-PIL-clean-20.06.12
Date of last change:2012/10/04
Final SPC
|
Olmesartan_HCT 40 mg_12,5_25 mg-SmPC-clean-20.06.12
Date of last change:2012/10/04
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase